Pfizer-BioNTech reports positive results for Covid-19 vaccine trail in children aged 5 to 11 years
Pfizer and its partner BioNTech have announced positive topline results from a pivotal trial of their Covid-19 vaccine in children aged 5 to 11 years. The Phase II/III